BOTHELL, Wash., May 4 /PRNewswire-FirstCall/ -- Helix BioMedix (HXBM.OB),
a developer of synthetic bioactive peptides, today announced that it will hold
a live web cast of its 2005 Annual Meeting of Stockholders on Wednesday, May
11, 2005 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). The annual
meeting is being held in the Boardroom of PRIME Hotel & Suites, 19333 North
Creek Parkway, Bothell, Washington and will be hosted by R. Stephen Beatty,
President and CEO.
The annual meeting as well as a general corporate update presentation will
be available online at http://www.helixbiomedix.com in an audio listen-only basis.
The link to the webcast can be found within the Investors section of the
Company's website or alternatively at
http://www.visualwebcaster.com/event.asp?id=28653 . A replay of the annual
meeting will be archived for 90 days.
About Helix BioMedix
Helix BioMedix, Inc. is an early-stage biotechnology company that has a
portfolio of issued patents that covers six distinct classes of peptides,
covering over 100,000 unique peptide sequences. The company's mission is to
become the industry leader in developing and commercializing small proteins
known as bioactive peptides. The antimicrobial and wound healing properties of
these peptides qualify them for inclusion in a wide range of both
pharmaceutical and consumer products. The company is currently focused on the
development of selected peptides as topical anti-infectives and in wound
healing. Non-pharmaceutical applications being pursued by Helix BioMedix
include adjuvants for cosmetics/cosmeceuticals, personal care, plant health,
animal health and wide-spectrum biocides. More information about the company
and its proprietary peptides can be found on the company's website at
http://www.helixbiomedix.com.
Contact:
Helix BioMedix, Inc.
David Kirske, 425-402-8400
dkirske@helixbiomedix.com
or
Investor Relations:
Cameron Associates
Alison Ziegler, 212-554-5469
alison@cameronassoc.com
SOURCE Helix BioMedix, Inc.
 back to top
Related links:
http://www.helixbiomedix.com
CONTACT:
David Kirske of Helix BioMedix, Inc.,
+1-425-402-8400, or dkirske@helixbiomedix.com; or investors,
Alison Ziegler of Cameron Associates, +1-212-554-5469, or
alison@cameronassoc.com, for Helix BioMedix, Inc.
|
